A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

Clinical trial NCT02932618 · COMPLETED

Trial details

NCT number: NCT02932618
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease

Start date: 2017-11-06
Primary completion: 2026-04-17
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.